The Membrane Protein Sortilin Can be Targeted to Inhibit Pancreatic Cancer Cell Invasion
June 11, 2020 | Histopathology
Freshly released on The American Journal of Pathology, Lab.Equipment has curated this new article for your everyday Pathology industry news fix:
Pancreatic cancer has a dismal prognosis and there is no targeted therapy against this malignancy. The neuronal membrane protein sortilin is emerging as a regulator of cancer cell development, but its expression and impact in pancreatic cancer is unknown. In this study, we found that sortilin expression was higher in pancreatic cell lines vs normal pancreatic ductal epithelial cells, as demonstrated by Western blot and mass spectrometry. The increased sortilin level in pancreatic cancer cells was confirmed by immunohistochemistry in a series of 99 human pancreatic adenocarcinomas vs 48 normal pancreatic tissues (p=0.0014).... Want to read more? Visit The American Journal of Pathology Blog.
Working in the Histopath industry and scouting for multipurpose Histopathology lab equipment for your workroom? Go through Lab.Equipment’s comprehensive range of Histopath equipment designed and produced by well-established manufacturers including:
Get user-friendly and valuable Histopath lab equipment for numerous pathological tests such as:
Focusing on other applications? You can count on Lab.Equipment for needed assistance. Improve facility efficiency with lab equipment for other industries including veterinary, environmental, food testing, and more. Find what you require for your application here.